Use of heparins in patients with cancer : individual participant data metaanalysis of randomised trials study protocol

ABSTRACT: Introduction: Parenteral anticoagulants may improve outcomes in patients with cancer by reducing risk of venous thromboembolic disease and through a direct antitumor effect. Study-level systematic reviews indicate a reduction in venous thromboembolism and provide moderate confidence that a...

Full description

Autores:

Flórez Gómez, Iván Darío
Ventresca, Matthew
Crowther, Mark
Schünemann, Holger J.
Briel, Matthias
Zhou, Qi
García, David
Lyman, Gary
Noble, Simon
Macbeth, Fergus
Griffiths, Gareth
DiNisio, Marcello
Lorio, Alfonso
Beyene, Joseph
Mbuagbaw, Lawrence
Neumann, Ignacio
Van Es, Nick
Brouwers, Melissa
Brozek, Jan
Guyatt, Gordon
Levine, Mark
Moll, Stephan
Santesso, Nancy
Streiff, Michael
Baldeh, Tejan
Gurunlu Alma, Ozlem
Solh, Ziad
Ageno, Walter
Marcucci, Maura
Bozas, George
Zulian, Gilbert
Maraveyas, Anthony
Lebeau, Bernard
Buller, Harry
Evans, Jessica
McBane, Robert
Bleker, Suzanne
Pelzer, Uwe
Akl, Elie A.

Tipo de recurso:

Review article

Fecha de publicación:

2016

Institución:

Universidad de Antioquia

Repositorio:

Repositorio UdeA

Idioma:

eng

OAI Identifier:

oai:bibliotecadigital.udea.edu.co:10495/32152

Acceso en línea:

https://hdl.handle.net/10495/32152

Palabra clave:

Anticoagulantes
Anticoagulants
Esquema de Medicación
Drug Administration Schedule
Heparina
Heparin
Neoplasias
Neoplasms
Calidad de Vida
Quality of Life
Tromboembolia Venosa
Venous Thromboembolism

Rights

openAccess

License

http://creativecommons.org/licenses/by/2.5/co/